LTFS
FATE icon

Ladenburg Thalmann Financial Services’s Fate Therapeutics FATE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5K Sell
272
-2,228
-89% -$35.4K ﹤0.01% 4762
2019
Q3 		$39K Hold
2,500
– – ﹤0.01% 3601
2019
Q2 		$51K Buy
2,500
+100
+4% +$1.8K ﹤0.01% 3447
2019
Q1 		$42K Buy
+2,400
New +$37.9K ﹤0.01% 3516
2018
Q4 		– Sell
-703
Closed -$11K – 5241
2018
Q3 		$11K Hold
703
– – ﹤0.01% 4227
2018
Q2 		$7K Hold
703
– – ﹤0.01% 4431
2018
Q1 		$7K Buy
+703
New +$6.74K ﹤0.01% 4431

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FATE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Fate Therapeutics (FATE) stake by 89% in Q4 2019, selling an estimated $35.4K and leaving 272 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4762.

Ladenburg Thalmann Financial Services first reported a position in FATE in Q1 2018 and has held it in 7 quarters since. The position peaked at $51K in Q2 2019. 147 funds tracked by Wall St. Rank hold FATE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 272 shares of Fate Therapeutics worth $5K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 2,228 Fate Therapeutics shares in Q4 2019, an estimated $35.4K.
  • Fate Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4762 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Fate Therapeutics in Q1 2018 and has held it in 7 quarters since.
  • Ladenburg Thalmann Financial Services's Fate Therapeutics position peaked at $51K in Q2 2019.
  • 147 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.